In vivo, with HIF-1a activation, HIF-1a can increase VEGF expression through gene regulation, making the body produce more VEGF.[28] After VEGF binds to its receptor, the endothelial cell structure changes, and vascular permeability increases, which eventually causes tissue edema and induces AMS. Here, HIF1A is linked to ablepharon macrostomia syndrome.